Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120043333 | 12004333 | 3 | F | 20140615 | 20160909 | 20160204 | 20160915 | PER | US-ELI_LILLY_AND_COMPANY-US201602001007 | ELI LILLY AND CO | 41.09 | YR | M | Y | 82.00000 | KG | 20160915 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120043333 | 12004333 | 1 | PS | AXIRON | TESTOSTERONE | 1 | Unknown | UNK, UNKNOWN | U | 22504 | ORAL LIQUID | QD | |||||||
| 120043333 | 12004333 | 2 | SS | TESTOSTERONE. | TESTOSTERONE | 1 | Intramuscular | 300 MG, MONTHLY (1/M) | U | U | 0 | 300 | MG | /month | |||||
| 120043333 | 12004333 | 3 | C | ARTIFICIAL TEARS /00222401/ | 2 | UNK, EVERY 6 HRS | U | U | 0 | Q6H | |||||||||
| 120043333 | 12004333 | 4 | C | B COMPLEX WITH B-12 | 2 | UNK, QD | U | U | 0 | QD | |||||||||
| 120043333 | 12004333 | 5 | C | CALCIUM 600 PLUS VITAMIN D3 | 2 | UNK, BID | U | U | 0 | BID | |||||||||
| 120043333 | 12004333 | 6 | C | CIALIS | TADALAFIL | 1 | Oral | 5 MG, PRN | U | U | 0 | 5 | MG | ||||||
| 120043333 | 12004333 | 7 | C | FLONASE /00908302/ | MOMETASONE FUROATE | 1 | Nasal | .2 MG, QD | U | U | 0 | QD | |||||||
| 120043333 | 12004333 | 8 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 1 MG, QD | U | U | 0 | 1 | MG | QD | |||||
| 120043333 | 12004333 | 9 | C | HUMALOG | INSULIN LISPRO | 1 | U | U | 0 | ||||||||||
| 120043333 | 12004333 | 10 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 20 MG, QD | U | U | 0 | 20 | MG | QD | |||||
| 120043333 | 12004333 | 11 | C | HCTZ | HYDROCHLOROTHIAZIDE | 1 | Oral | 12.5 MG, QD | U | U | 0 | 12.5 | MG | QD | |||||
| 120043333 | 12004333 | 12 | C | LORATADINE. | LORATADINE | 1 | Oral | 10 MG, QD | U | U | 0 | 10 | MG | QD | |||||
| 120043333 | 12004333 | 13 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 25 MG, BID | U | U | 0 | 25 | MG | BID | |||||
| 120043333 | 12004333 | 14 | C | MULTIVITAMIN /00097801/ | VITAMINS | 1 | U | U | 0 | QD | |||||||||
| 120043333 | 12004333 | 15 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, QD | U | U | 0 | 40 | MG | QD | |||||
| 120043333 | 12004333 | 16 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | 40 MG, QD | U | U | 0 | 40 | MG | QD | |||||
| 120043333 | 12004333 | 17 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 60 MG, QD | U | U | 0 | 60 | MG | QD | |||||
| 120043333 | 12004333 | 18 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | .09 MG, UNK | U | U | 0 | |||||||||
| 120043333 | 12004333 | 19 | C | SENOKOT-S | DOCUSATE SODIUMSENNOSIDES | 1 | UNK, BID | U | U | 0 | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120043333 | 12004333 | 1 | Androgen replacement therapy |
| 120043333 | 12004333 | 2 | Androgen replacement therapy |
| 120043333 | 12004333 | 19 | Constipation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120043333 | 12004333 | HO |
| 120043333 | 12004333 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120043333 | 12004333 | Cerebrovascular accident | |
| 120043333 | 12004333 | Deep vein thrombosis | |
| 120043333 | 12004333 | Pulmonary embolism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120043333 | 12004333 | 1 | 201312 | 201406 | 0 | |
| 120043333 | 12004333 | 2 | 201307 | 0 |